Product Details
| Product Name:
IDT307 |
CAS No.:
1141-41-9 |
| Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
| Name | IDT307 |
| Description | IDT307, identified as APP+, is an analog of the organic cation MPP+ and serves as a specific fluorescent substrate for DAT (dopamine transporter). |
| In vitro | IDT307, an analog of the organic cation MPP+, is actively transported across the apical (CSF-facing) membrane of CP epithelial cells, with its uptake being sensitive to quinine-mediated inhibition via the PMAT pathway[1]. Furthermore, studies reveal that CP tissues from Pmat knockout mice exhibit a significant reduction (~70%) in IDT307 uptake and intracellular accumulation[1]. |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Keywords | IDT307 | IDT 307 | IDT-307 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$0.00/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2024-08-15 |
United States